Scarica l'app Stockscreener
0.7663
2.11%
-0.0165
Precedente Chiudi:
$0.7828
Aprire:
$0.784
Volume 24 ore:
309.25K
Relative Volume:
0.27
Capitalizzazione di mercato:
$49.28M
Reddito:
$300.00K
Utile/perdita netta:
$-27.61M
Rapporto P/E:
-1.3265
EPS:
-0.5777
Flusso di cassa netto:
$-22.17M
1 W Prestazione:
-12.02%
1M Prestazione:
-35.06%
6M Prestazione:
-63.68%
1 anno Prestazione:
-9.37%
Intervallo 1D:
$0.7601
$0.7999
Intervallo di 1 settimana:
$0.7328
$0.95
Portata 52W:
$0.7328
$3.82
Ibio Inc Stock (IBIO) Company Profile
Nome
Ibio Inc
Settore
Industria
Telefono
302 355-0650
Indirizzo
600 MADISON AVENUE, SUITE 1601, NEW YORK
Compare IBIO vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IBIO
Ibio Inc
|
0.7663 | 49.28M | 300.00K | -27.61M | -22.17M | -0.5777 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Ibio Inc Stock (IBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-17 | Iniziato | H.C. Wainwright | Buy |
| 2026-06-08 | Iniziato | Raymond James | Outperform |
| 2026-06-05 | Iniziato | B. Riley Securities | Buy |
| 2025-10-21 | Iniziato | Oppenheimer | Outperform |
| 2025-10-17 | Iniziato | Leerink Partners | Outperform |
| 2024-05-28 | Iniziato | Chardan Capital Markets | Buy |
| 2021-11-29 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-01-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-06-26 | Iniziato | Alliance Global Partners | Buy |
Mostra tutto
Ibio Inc Borsa (IBIO) Ultime notizie
Form 4 Ibio Inc: Gary Sender (Director) For: 14 October By Investing.com - Investing.com Canada
Form 4 Ibio Inc: Gary Sender (Director) For: 14 October By Investing.com - Investing.com South Africa
Form 4 Ibio Inc: Antonio Bernardino Guimaraes Parada (Director) For: 14 October By Investing.com - Investing.com South Africa
At $0.78 per share, 38,000 options go to iBio (IBIO) director Elizabeth Stoner. - Stock Titan
38,000 options granted to iBio (IBIO) director Alexandra Kropotova vest monthly over 12 months. - Stock Titan
A director receives 38,000 iBio (IBIO) stock options with a $0.78 exercise price. - Stock Titan
A 6.25M-share passive stake in iBio (IBIO) has one direct holder and five reporting parties. - Stock Titan
Johnson & Johnson Stock Has Surged 44%, Can Its Growth Justify the Valuation? - Insider Monkey
iBio, Inc. Common Stock (NASDAQ: IBIO) Share Price, IBIO Stock News, IBIO Share Price & Updates - Kalkine
New iBio (NASDAQ: IBIO) investor presentation goes public - Stock Titan
iBio (NASDAQ:IBIO) Stock Rating Lowered by Wall Street Zen - marketbeat.com
iBio, Inc. (IBIO) Stock Price & News - Syfe
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape By Investing.com - Investing.com South Africa
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape By Investing.com - Investing.com Canada
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape - Investing.com
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape By Investing.com - Investing.com India
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape By Investing.com - Investing.com UK
iBio (NASDAQ: IBIO) Shareholders Set to Vote on 500 Million Share Increase on October 14, 2026 - Kalkine Media
iBio (NASDAQ:IBIO) Upgraded by Wall Street Zen to Hold Rating - marketbeat.com
iBio, Inc. SEC Filing (Sep 4, 2026) - stocktitan.net
Hundreds of millions of new shares on ballot at iBio (IBIO) - Stock Titan
iBio, Inc. Common Stock (NASDAQ: IBIO) Share Price, IBIO Stock News, IBIO Share Price & Updates - kalkine.ca
iBio, Inc. (NASDAQ:IBIO) Receives Average Rating of "Buy" from Brokerages - marketbeat.com
iBio Q2 EPS Forecast Decreased by Brookline Capital Markets - MarketBeat
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference - Yahoo Finance
Insiders Give Up US$33k As iBio Stock Drops To US$1.27 - simplywall.st
iBio Inc. (IBIO) Slides 6.6% to $1.27 as Biotech Stock Approaches Key SupportWyckoff Distribution - dars.gov.et
B. Riley Securities Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $6 - moomoo.com
iBio Advances IBIO-600 Through First Phase 1 Dose Escalation As Cash And Investments Reach $88 Million - Pulse 2.0
iBio Inc. (IBIO) Slides 6.6% to $1.27 as Biotech Stock Approaches Key SupportVolume Rate Change - dars.gov.et
iBio, Inc. Revenue Breakdown – NASDAQ:IBIO - TradingView
iBio FY2026 Net Loss Widens to $33M on Higher R&D Spending - Minichart
iBio FY 2026: Revenue $100K, Net income ($33.04M), EPS ($0.32) — 10-K Summary - tradingview.com
iBio reports $33 million loss for fiscal 2026, advances pipeline By Investing.com - Investing.com Canada
IBio Reports $33.0 Million Fiscal 2026 Net Loss as Phase 1 Advances - Moomoo
iBio Reports $33.0 Million Fiscal 2026 Net Loss as Phase 1 Advances - Quiver Quantitative
IBIO: Advanced clinical pipeline and secured funding, extending cash runway into fiscal 2028 - TradingView
iBio (NASDAQ:IBIO) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
iBio reports FY2026 net loss of $33.0M, revenue $0.1M and $88.0M cash and investments - TradingView
iBio reports $33 million loss for fiscal 2026, advances pipeline By Investing.com - Investing.com Nigeria
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - manilatimes.net
iBio Reports Fiscal 2026 Financial Results and Corporate Update Highlighting Clinical and Pipeline Progress - Quiver Quantitative
IBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - marketscreener.com
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - au.finance.yahoo.com
iBio FY26 Results: Net loss widens 80% to $33.0M, R&D up 136% - scanx.trade
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewswire
iBio (IBIO) Expected to Release Quarterly Earnings on Friday - MarketBeat
iBio (NASDAQ:IBIO) Cut to "Sell" at Wall Street Zen - MarketBeat
iBio (NYSE: IBIO) seeks 500M shares, revises equity plan for warrants - Stock Titan
iBio (IBIO) Chart: Closes 1.72% Lower at $1.43 for the Current Session; Current Setup: the Near-Term Reference Band Stretches From $1.36 to $1.50 in the Available RecordMax Pain Level - vinanet.vn
Ibio Inc Azioni (IBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ibio Inc Azioni (IBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Duran Felipe | Chief Financial Officer |
Mar 19 '26 |
Buy |
2.02 |
24,835 |
50,132 |
35,974 |
| Brenner Martin | See Remarks |
Mar 19 '26 |
Buy |
2.02 |
12,336 |
24,919 |
30,652 |
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):